Literature DB >> 3260374

A novel effect of EGF on mRNA stability.

Y Jinno1, G T Merlino, I Pastan.   

Abstract

Expression of the epidermal growth factor (EGF) receptor gene is stimulated by EGF and the phorbol ester, 4 beta-phorbol 12-myristate 13-acetate (PMA). PMA elevates EGF receptor mRNA levels in human KB epidermoid carcinoma cells, but does not significantly affect the half-life of this mRNA when its decay is examined after the addition of actinomycin D. In contrast, EGF greatly prolongs the half-life of EGF receptor mRNA suggesting a possible mechanism for the stimulatory effect of EGF on EGF receptor mRNA levels. EGF also stabilizes beta-tubulin and beta-actin mRNAs but has very little effect on the degradation of total mRNA.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3260374      PMCID: PMC336709          DOI: 10.1093/nar/16.11.4957

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  21 in total

Review 1.  Epidermal growth factor.

Authors:  G Carpenter; S Cohen
Journal:  Annu Rev Biochem       Date:  1979       Impact factor: 23.643

2.  Unpolymerized tubulin modulates the level of tubulin mRNAs.

Authors:  D W Cleveland; M A Lopata; P Sherline; M W Kirschner
Journal:  Cell       Date:  1981-08       Impact factor: 41.582

3.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

Authors:  D A Melton; P A Krieg; M R Rebagliati; T Maniatis; K Zinn; M R Green
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

4.  Specific stimulation of actin gene transcription by epidermal growth factor and cycloheximide.

Authors:  P K Elder; L J Schmidt; T Ono; M J Getz
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

5.  Induction of c-fos gene and protein by growth factors precedes activation of c-myc.

Authors:  R Müller; R Bravo; J Burckhardt; T Curran
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

6.  Extreme instability of myc mRNA in normal and transformed human cells.

Authors:  C Dani; J M Blanchard; M Piechaczyk; S El Sabouty; L Marty; P Jeanteur
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

7.  Epidermal growth factor rapidly stimulates prolactin gene transcription.

Authors:  G H Murdoch; E Potter; A K Nicolaisen; R M Evans; M G Rosenfeld
Journal:  Nature       Date:  1982-11-11       Impact factor: 49.962

8.  Detection, sizing, and quantitation of polyadenylated ribonucleic acid in the nanogram-picogram range.

Authors:  S Tracy; D E Kohne
Journal:  Biochemistry       Date:  1980-08-05       Impact factor: 3.162

9.  Isolation and characterization of full-length cDNA clones for human alpha-, beta-, and gamma-actin mRNAs: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed.

Authors:  P Gunning; P Ponte; H Okayama; J Engel; H Blau; L Kedes
Journal:  Mol Cell Biol       Date:  1983-05       Impact factor: 4.272

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  11 in total

Review 1.  MRNA stability and the control of gene expression: implications for human disease.

Authors:  Elysia M Hollams; Keith M Giles; Andrew M Thomson; Peter J Leedman
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

2.  Synergistic and multidimensional regulation of plasminogen activator inhibitor type 1 expression by transforming growth factor type β and epidermal growth factor.

Authors:  Xiaoling Song; Frederic W Thalacker; Marit Nilsen-Hamilton
Journal:  J Biol Chem       Date:  2012-02-10       Impact factor: 5.157

3.  Inhibition of epidermal growth factor receptor biosynthesis caused by the src oncogene product, pp60v-src.

Authors:  W J Wasilenko; M Nori; N Testerman; M J Weber
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

4.  Characterization of an inducible promoter system to investigate decay of stable mRNA molecules.

Authors:  S R Helms; F M Rottman
Journal:  Nucleic Acids Res       Date:  1990-01-25       Impact factor: 16.971

5.  Human enterocyte (Caco-2) migration is modulated in vitro by extracellular matrix composition and epidermal growth factor.

Authors:  M D Basson; I M Modlin; J A Madri
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

6.  Transcriptional regulation of plasminogen activator inhibitor type-1 mRNA in Hep G2 cells by epidermal growth factor.

Authors:  W E Hopkins; D R Westerhausen; B E Sobel; J J Billadello
Journal:  Nucleic Acids Res       Date:  1991-01-11       Impact factor: 16.971

7.  Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas.

Authors:  Ajay K Yadav; Jaclyn J Renfrow; Denise M Scholtens; Hehuang Xie; George E Duran; Claudia Bredel; Hannes Vogel; James P Chandler; Arnab Chakravarti; Pierre A Robe; Sunit Das; Adrienne C Scheck; John A Kessler; Marcelo B Soares; Branimir I Sikic; Griffith R Harsh; Markus Bredel
Journal:  JAMA       Date:  2009-07-15       Impact factor: 56.272

8.  Epidermal growth factor-stimulated parathyroid hormone-related protein expression involves increased gene transcription and mRNA stability.

Authors:  J K Heath; J Southby; S Fukumoto; L M O'Keeffe; T J Martin; M T Gillespie
Journal:  Biochem J       Date:  1995-04-01       Impact factor: 3.857

9.  The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor.

Authors:  W E Miller; H S Earp; N Raab-Traub
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

10.  Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells.

Authors:  D Seth; K Shaw; J Jazayeri; P J Leedman
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.